You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: _data/authors.yml
+7-8Lines changed: 7 additions & 8 deletions
Original file line number
Diff line number
Diff line change
@@ -6,15 +6,15 @@ michael_keiser:
6
6
name: Michael Keiser, PhD
7
7
email: keiser@keiserlab.org
8
8
bio: "pharm chem; bts; bchsi; kifn; ind"
9
-
bio_long: "<p>Michael is a Chan Zuckerberg Initiative Ben Barres Investigator and a Paul G. Allen Distinguished Investigator. Michael joined the UCSF faculty in 2014, in the Dept. of Pharmaceutical Chemistry and the Institute for Neurodegenerative Diseases, with appointments in the Dept. of Bioengineering & Therapeutic Sciences and the Bakar Computational Health Sciences Institute. He is also a member of the Quantitative Biosciences Institute and the Kavli Institute for Fundamental Neuroscience at UCSF.</p>
10
-
<p>Before this, he co-founded a startup bringing systems pharmacology methods for drug-target prediction to pharma and the US FDA, where they are in use today. During his bioinformatics Ph.D. at UCSF as a NSF Fellow, Michael developed techniques to relate drugs and proteins from the statistical similarity of their ligands, such as the Similarity Ensemble Approach (SEA). He holds multiple degrees from Stanford, including a BSc. in Computer Science.</p>"
9
+
bio_long: >
10
+
<p>Michael is a Chan Zuckerberg Initiative Ben Barres Investigator and a Paul G. Allen Distinguished Investigator. Michael joined the UCSF faculty in 2014, in the Dept. of Pharmaceutical Chemistry and the Institute for Neurodegenerative Diseases, with appointments in the Dept. of Bioengineering & Therapeutic Sciences and the Bakar Computational Health Sciences Institute. He is also a member of the Quantitative Biosciences Institute and the Kavli Institute for Fundamental Neuroscience at UCSF.</p>
11
+
<p>Before this, he co-founded a startup bringing systems pharmacology methods for drug-target prediction to pharma and the US FDA, where they are in use today. During his bioinformatics Ph.D. at UCSF as a NSF Fellow, Michael developed techniques to relate drugs and proteins from the statistical similarity of their ligands, such as the Similarity Ensemble Approach (SEA). He holds multiple degrees from Stanford, including a BSc. in Computer Science.</p>
11
12
avatar: /assets/images/people/bio-keiser.jpg
12
13
title: Associate Professor; CZI Ben Barres Investigator; Allen Distinguished Investigator
13
14
github: mjke
14
15
linkedin: keiser
15
16
google:
16
17
scholar: 6GGtbegAAAAJ
17
-
#plus: MichaelKeiser
18
18
ucsf_profiles: michael.keiser
19
19
my_ncbi: michael.keiser.1
20
20
ncbi_id: Keiser MJ
@@ -332,7 +332,6 @@ michael_mysinger:
332
332
title: "Principal Scientist"
333
333
github: mmysinger
334
334
linkedin: michael-mysinger-phd-536ba5b
335
-
github: mmysinger
336
335
ncbi_id: Mysinger MM
337
336
type: alumn
338
337
@@ -472,7 +471,6 @@ yannah_melle:
472
471
bio_long: "Visiting Scholar (2020), SRTP Intern (2019). Yannah was a 4th year undergraduate student studying Chemical Engineering at the University of Michigan. In the Keiser lab, she investigated ligand-based drug discovery with cheminformatics and machine learning, using deep neural networks to predict the bioactivity of ligands for protein targets. She is excited about pursuing research and a career in biotechnology. Outside of academia Yannah is a foodie who loves to experience different cultures and do anything outdoors."
473
472
avatar: /assets/images/people/bio-melle.jpg
474
473
title: "Cheminformatics Engineer"
475
-
linkedin:
476
474
github: JYang25
477
475
ncbi_id: Melle Y
478
476
linkedin: yjumelle
@@ -556,11 +554,12 @@ dan_wong:
556
554
name: Daniel Wong, PhD
557
555
email: dwong@keiserlab.org
558
556
bio: "Pfizer"
559
-
bio_long: "Grad Student, bioinformatics (2018-2022). Daniel studied Computer Science and Biochemistry at UC Berkeley, and was in a PhD program within the Integrative Program in Quantitative Biology. He is interested in developing machine learning methodologies in improving human health, particularly in the fields of neurodegeneration and pharmacology. Daniel was co-mentored in the [Butte Lab](http://buttelab.ucsf.edu/).
557
+
bio_long: >
558
+
Grad Student, bioinformatics (2018-2022). Daniel studied Computer Science and Biochemistry at UC Berkeley, and was in a PhD program within the Integrative Program in Quantitative Biology. He is interested in developing machine learning methodologies in improving human health, particularly in the fields of neurodegeneration and pharmacology. Daniel was co-mentored in the [Butte Lab](http://buttelab.ucsf.edu/).
560
559
561
-
- [Prototype of running clinical trials in an untrustworthy environment using blockchain](https://doi.org/10.1038/s41467-019-08874-y). <ins>Wong DR</ins>, Bhattacharya S, Butte, AJ. **Nat Commun**. 2019 Feb 22.
560
+
- [Prototype of running clinical trials in an untrustworthy environment using blockchain](https://doi.org/10.1038/s41467-019-08874-y). <ins>Wong DR</ins>, Bhattacharya S, Butte, AJ. **Nat Commun**. 2019 Feb 22.
562
561
563
-
- [Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding](https://pubmed.ncbi.nlm.nih.gov/32786289/). Newberry RW, Arhar T, Costello J, ... <ins>Wong DR</ins>, Wong G, Redding S, Chow ED, DeGrado WF, Kampmann M. **ACS Chem Biol**. 2020 Aug 21."
562
+
- [Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding](https://pubmed.ncbi.nlm.nih.gov/32786289/). Newberry RW, Arhar T, Costello J, ... <ins>Wong DR</ins>, Wong G, Redding S, Chow ED, DeGrado WF, Kampmann M. **ACS Chem Biol**. 2020 Aug 21.
0 commit comments